The distribution and properties of receptors for corticotropin-releasing factor (CRF) were analyzed in the brain of cynomolgus monkeys. Binding of [125I]tyrosine-labeled ovine CRF to frontal cortex and amygdala membrane-rich fractions was saturable, specific, and time-and temperaturedependent, reaching equilibrium in 30 min at 23TC. Scatchard analysis of the binding data indicated one class of high-affinity sites with a Kd of 1 nM and a concentration of 125 fmol/mg (,30% of the receptor number in monkey anterior pituitary membranes). As in the rat pituitary and brain, CRF receptors in monkey cerebral cortex and amygdala were coupled to adenylate cyclase. Autoradiographic analysis of specific CRF binding in brain sections revealed that the receptors were widely distributed in the cerebral cortex and limbic system. Receptor density was highest in the pars tuberalis of the pituitary and throughout the cerebral cortex, specifically in the prefrontal, frontal, orbital, cingulate, insular, and temporal areas, and in the cerebellar cortex. A very high binding density was also present in the hippocampus, mainly in the dentate gyrus, and in the arcuate nucleus and nucleus tuberis lateralis. A high binding density was present in the amygdaloid complex and mammary bodies, olfactory tubercle, and medial portion of the dorsomedial nucleus of the thalamus. A moderate binding density was found in the nucleus accumbens, claustrum, caudate-putamen, paraventricular and posterior lateral nuclei of the thalamus, inferior colliculus, and dorsal parabrachial nucleus. A low binding density was present in the superior colliculus, locus coeruleus, substantia gelatinosa, preoptic area, septal area, and bed nucleus of the stria terminalis. These data demonstrate that receptors for CRF are present within the primate brain at areas related to the central control of visceral function and behavior, suggesting that brain CRF may serve as a neurotransmitter in the coordination of endocrine and neural mechanisms involved in the response to stress.
of the dorsomedial nucleus of the thalamus. A moderate binding density was found in the nucleus accumbens, claustrum, caudate-putamen, paraventricular and posterior lateral nuclei of the thalamus, inferior colliculus, and dorsal parabrachial nucleus. A low binding density was present in the superior colliculus, locus coeruleus, substantia gelatinosa, preoptic area, septal area, and bed nucleus of the stria terminalis. These data demonstrate that receptors for CRF are present within the primate brain at areas related to the central control of visceral function and behavior, suggesting that brain CRF may serve as a neurotransmitter in the coordination of endocrine and neural mechanisms involved in the response to stress.
In addition to its role as a major regulator of corticotropin (ACTH) release from the anterior pituitary (1) , corticotropinreleasing factor (CRF) also exerts direct actions within the central nervous system in several animal species. Intracerebroventricular administration of CRF in experimental animals results in altered behavior and activates the hypothalamic-pituitary adrenal axis and the sympathetic nervous system, similar to the changes observed during stress (1) (2) (3) (4) . Immunoreactive CRF has been found in several extrahypothalamic sites in the brain, including many parts of the limbic system and centers known to control the autonomic nervous system (1, (5) (6) (7) . These findings suggest that the peptide acts as a neurotransmitter in the brain to modulate the integrated responses to stress. This view is supported by the demonstration that CRF receptors are present in the rat brain, with a distribution corresponding to the components of the limbic system and cerebral cortex (8) . There is evidence indicating That CRF may also be involved in the control of central nervous system function in primates including man. In this regard, changes in behavior and visceral function have been observed in the monkey after intracerebroventricular administration of CRF (4) . Also, many patients with depression exhibit hyperactivity of the pituitary-adrenal axis, which could arise from a central disorder that is accompanied by increased secretion of CRF (9) . To determine the sites at which CRF exerts its putative central actions in the primate, we have characterized CRF receptors and analyzed their anatomical distribution in the monkey brain.
MATERIALS AND METHODS
Ovine CRF (oCRF) and [Tyr]oCRF were synthesized as described (10) The pellet was washed with 1 ml of polyethylene glycol solution and the tip of the tube was severed and analyzed for bound radioactivity in a y spectrometer. Nonspecific binding determined in the presence of 1 ,uM oCRF was <2% of the total radioactivity added.
For autoradiographic mapping of CRF binding, 20-,um frozen sections were processed as described (8 Autoradiographic Mapping of CRF Receptors in Monkey Brain. In the monkey brain, CRF receptors were located in the neocortex, several components of the limbic system, and the cerebellum, similar to the distribution of CRF receptors in the rat brain ( Fig. 2 and Table 1 ). CRF receptors were found throughout the brain cortex, with markedly higher binding in the orbital (Fig. 2 A-C) , prefrontal, frontal ( Fig.  2A) , insular ( Fig. 2 A-E), temporal ( Fig. 2 B-E) , and cingulate areas ( Fig. 2 A-E) . In most cortical areas the receptors were confined to layers I and II, but in the frontal, orbital, insular, and temporal areas, the inner layers of the cortex were also labeled.
The hippocampus also contained a high concentration of CRF receptors with predominant labeling in the dentate gyrus ( Fig. 2 E and F Fig. 2 C and D) , mamillary bodies (Fig. 2E) , olfactory tubercle (Fig. 2B) , and the medial portion of the dorsomedial thalamic nucleus (Fig. 2E) .
Moderate concentrations of receptors (optical densities of 200-350) were found in the nucleus accumbens (Fig. 2B) , caudate-putamen (Fig. 2 A-D) , claustrum ( Fig. 2 B and C) , paraventricular nucleus of the thalamus (Fig. 2D) , posterior lateral nucleus of the thalamus (Fig. 2F) , inferior colliculus (Fig. 2G) , and dorsal parabrachial nucleus (Fig. 2H) . Low concentrations of receptors (optical densities < 200) were found in the lateral septal nuclei, septal area, bed nucleus of the stria terminalis (Fig. 2C) , anterior ventricular nucleus thalamus, preoptic area (Fig. 2C) , lateral geniculate nucleus (Fig. 2F) , superior colliculus (Fig. 2F) , substantia nigra, and substantia gelatinosa.
The cerebellum contained a high concentration of CRF receptors that were distributed throughout with predominant labeling in the granular layer ( Fig. 2 G and H Data are means ± SD of optical density values in three sections from one experiment after subtracting nonspecific background (260 ± 1.6). In each section the nonspecific background was uniform.
well developed only in primates, and especially in man. These areas receive abundant innervation from the dorsomedial nucleus of the thalamus, which relays impulses from several autonomic centers (15) . This area of the thalamus, which plays an important role in emotional responses, also contains abundant CRF receptors.
CRF receptors were also found in two hypothalamic areas involved in the control of gonadotropin secretion, the preoptic area and the arcuate nucleus. A possible role for CRF in the control of sexual function has been supported by studies showing decreases in luteinizing hormone release (16) and inhibition of sexual behavior in the female rat (17) after CRF injection in the arcuate-ventromedial hypothalamic regions. The presence of CRF receptors in these areas in the primate brain suggests that CRF may also influence gonadotropin secretion in man and could be involved in the mechanism of altered gonadal function during prolonged stress. The arcuate nucleus has projections to a number of hypothalamic and limbic structures that are rich in CRF and also in ACTH and P-endorphin (18) . Coexistence of CRF and opiocortin peptides has been described in many other structures that contain CRF receptors, such as the nucleus accumbens, stria terminalis, preoptic area, amygdala, geniculate bodies, locus coeruleus, and parabrachial nucleus (18) . The similar anatomical distribution of CRF and its receptors and of opiocortin peptides suggests that, as in the pituitary gland, both systems may be functionally related in the brain.
Also in the hypothalamus, it is interesting to note the very high concentration of CRF receptors in the nucleus tuberis lateralis, a structure of yet unknown function. This nucleus is particularly developed in primates (19) , and the abundance of CRF receptor at this site may provide some basis for the study of its function.
A high density of CRF receptors was also observed in the amygdala. This important component of the limbic system has both efferent and afferent connections with the cortical areas that contain the highest CRF receptor concentrations, namely, the frontal, orbital, cingulate, temporal, and insular cortices (20) (21) (22) . The amygdaloid nuclei also receive projections from the locus coeruleus, hypothalamus, and dorsomedial thalamic nucleus and have efferent projections to the dorsomedial thalamic nucleus, nucleus stria terminalis, preoptic area, septal regions, and arcuate nucleus (19, (23) (24) (25) . All of these areas that are connected to the amygdala were found to contain CRF receptors. It should be noted that the connections of the amygdala to the septal and preoptic area are unique for the higher mammals (24, 25) , a feature that correlates with the presence of CRF receptors in these regions in the monkey but not in the rat (8) . Electrical stimulation ofthe amygdala in experimental animals has been shown to cause arousal, attention, fear, and rage reactions associated with sympathetic activation (26) (27) (28) (29) . These reactions are similar to those observed during stress and after intracerebroventricular administration of CRF (1). Since CRF and its receptors are present in the amygdala, it is likely that the peptide may have a role in the generation of some of these responses.
High CRF receptor concentrations were also present in the limbic lobe, which is composed of the cingulate and parahippocampal cortex and the hippocampus. This structure, referred to by some authors as the "visceral brain" because of its close relationship with the hypothalamus, also has connections with other limbic structures and the neocortex (30) . The limbic system has a primary role in the mechanisms that control behavior, emotion, and autonomic and endocrine function. A number ofthese limbic system-mediated responses can be mimicked by central administration of CRF. Intracerebroventricular injection of CRF in rat, dog, and monkey results in behavioral changes and activation of the hypothalamic-pituitary-adrenal axis (1, 4, 31, 32) and the sympathetic nervous system with the subsequent visceral and metabolic responses (1, (32) (33) (34) (35) . In chair-restrained monkeys, administration of CRF into the brain causes an increase in arousal consistent with limbic activation (31 (41) .
The presence of a peptide in nerve terminals at its sites of action in the brain is a criterion for consideration as a neurotransmitter. In the rat, extensive studies have demonstrated the presence of immunoreactive CRF in several extrahypothalamic areas including the sites at which CRF receptors are present. However, little information is available in this regard for monkey or man, for which studies have been limited mainly to descriptions of the hypothalamic pathways (42, 43) . In the squirrel monkey, cell bodies and fibers with projections to the median eminence have been localized in the paraventricular and supraoptic nuclei of the hypothalamus (42) . Similar localization of immunoreactive CRF to the paraventricular nucleus and median eminence has been described in the hypothalamus from human fetuses and newborns (43) . No detectable CRF receptors were found in these hypothalamic areas. This finding, which agrees with previous observations in the rat (8) , is consistent with the role of these areas as the source of CRF released to the portal circulation and not as targets for CRF action.
With respect to extrahypothalamic localization of the peptide, the presence of immunoreactive CRF has been observed in the circumventricular organs in Macacafuscata brain (44) , but there are no reports on CRF localization in the limbic system. Further studies are needed to clarify the extrahypothalamic localization of CRF in the primate brain.
Although the mechanisms by which CRF modulates neuronal activity and the exact physiological role of the peptide in the nervous system will require further study, the presence offunctional CRF receptors in discrete structures in the brain suggests that CRF modulates central nervous system function. These findings support the view that CRF participates in the integrated behavioral, visceral, and endocrine responses to stress by acting through its specific receptors in the central and peripheral nervous system, as well as in the pituitary gland.
